More on CAPR
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $19.70 |
|
|||
| Open | $19.70 | ||||
| 52 Wk High | $5.40 | ||||
| 52 Wk Low | $1.88 | ||||
| Day High | $19.70 | ||||
| Day Low | $19.70 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 109,606 | ||||
- Capricor Therapeutics (CAPR) Reiterated at Overweight by Cantor Fitzgerald
- Form 8-K CAPRICOR THERAPEUTICS, For: Jul 09
- Capricor Therapeutics (CAPR) Reiterates Overweight Rating Ahead of Upcoming PDUFA
- Form 4 CAPRICOR THERAPEUTICS, For: Jun 25 Filed by: Bergmann Anthony
- Form 4 CAPRICOR THERAPEUTICS, For: Jun 25 Filed by: Krasney Karen
- Capricor Therapeutics (CAPR) 4500 contracts of August 30 calls and 2900 contracts of August 20 puts trade
- Form 8-K CAPRICOR THERAPEUTICS, For: Jun 26
- FDA to review Capricor's DMD therapy at July advisory meeting
- Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
- Capricor shares five-year deramiocel data at DMD conference
Entities mentioned with CAPR
- FDA | View Related Stories »
- Twitter | View Related Stories »
- S3 | View Related Stories »
- Earnings | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
